Literature DB >> 22554539

Personalised medicine in oncology: questions for the next 20 years.

Jean-Yves Blay1, Denis Lacombe, Françoise Meunier, Roger Stupp.   

Abstract

Mesh：

Year:  2012        PMID： 22554539     DOI： 10.1016/S1470-2045(12)70156-0

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN： 1470-2045            Impact factor:   41.316


× No keyword cloud information.
  5 in total

Review 1.  Pre-graduate and post-graduate education in personalized medicine in the Czech Republic: statistics, analysis and recommendations.

Authors:  Jiri Polivka; Jiri Polivka; Marie Karlikova; Ondrej Topolcan
Journal:  EPMA J       Date:  2014-12-15       Impact factor: 6.543

2.  Sequencing-based breast cancer diagnostics as an alternative to routine biomarkers.

Authors:  Mattias Rantalainen; Daniel Klevebring; Johan Lindberg; Emma Ivansson; Gustaf Rosin; Lorand Kis; Fuat Celebioglu; Irma Fredriksson; Kamila Czene; Jan Frisell; Johan Hartman; Jonas Bergh; Henrik Grönberg
Journal:  Sci Rep       Date:  2016-11-30       Impact factor: 4.379

3.  Precision oncology in Latin America: current situation, challenges and perspectives.

Authors:  Ali Calderón-Aparicio; Andrea Orue
Journal:  Ecancermedicalscience       Date:  2019-04-03

4.  Heterogeneity of gene expression in murine squamous cell carcinoma development-the same tumor by different means.

Authors:  Noam Cohen; Nataly Kravchenko-Balasha; Shoshana Klein; Alexander Levitzki
Journal:  PLoS One       Date:  2013-03-18       Impact factor: 3.240

5.  A study of gene expression markers for predictive significance for bevacizumab benefit in patients with metastatic colon cancer: a translational research study of the Hellenic Cooperative Oncology Group (HeCOG).

Authors:  George Pentheroudakis; Vassiliki Kotoula; Elena Fountzilas; George Kouvatseas; George Basdanis; Ioannis Xanthakis; Thomas Makatsoris; Elpida Charalambous; Demetris Papamichael; Epaminontas Samantas; Pavlos Papakostas; Dimitrios Bafaloukos; Evangelia Razis; Christos Christodoulou; Ioannis Varthalitis; Nicholas Pavlidis; George Fountzilas
Journal:  BMC Cancer       Date:  2014-02-20       Impact factor: 4.430
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.